UNC13D
Basic information
Region (hg38): 17:75827225-75844785
Links
Phenotypes
GenCC
Source:
- familial hemophagocytic lymphohistiocytosis 3 (Strong), mode of inheritance: AR
- familial hemophagocytic lymphohistiocytosis 3 (Strong), mode of inheritance: AR
- hereditary hemophagocytic lymphohistiocytosis (Supportive), mode of inheritance: AR
- familial hemophagocytic lymphohistiocytosis 3 (Definitive), mode of inheritance: AR
- familial hemophagocytic lymphohistiocytosis 3 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hemophagocytic lymphohistiocytosis, familial 3 | AR | Allergy/Immunology/Infectious; Hematologic; Oncologic | Early recognition may allow prompt treatment, as individuals frequently have fatal outcomes unless treated by control of infectious triggers and chemoimmunotherapy, which can be beneficial; HSCT has been described | Allergy/Immunology/Infectious; Hematologic; Oncologic | 14622600; 16825436; 16278825; 17993578; 20301617; 21881043; 21303357; 21755595; 21931115; 22146525; 21674762; 32374962 |
ClinVar
This is a list of variants' phenotypes submitted to
- Familial_hemophagocytic_lymphohistiocytosis_3 (1523 variants)
- Inborn_genetic_diseases (142 variants)
- not_provided (116 variants)
- not_specified (89 variants)
- Autoinflammatory_syndrome (75 variants)
- UNC13D-related_disorder (45 variants)
- Familial_hemophagocytic_lymphohistiocytosis (18 variants)
- See_cases (5 variants)
- Intellectual_disability (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UNC13D gene is commonly pathogenic or not. These statistics are base on transcript: NM_000199242.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 421 | 431 | ||||
| missense | 11 | 506 | 27 | 550 | ||
| nonsense | 35 | 14 | 50 | |||
| start loss | 0 | |||||
| frameshift | 57 | 14 | 73 | |||
| splice donor/acceptor (+/-2bp) | 10 | 34 | 45 | |||
| Total | 105 | 73 | 517 | 448 | 6 |
Highest pathogenic variant AF is 0.00035217556
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| UNC13D | protein_coding | protein_coding | ENST00000207549 | 32 | 17493 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.09e-18 | 0.998 | 125591 | 0 | 157 | 125748 | 0.000624 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.241 | 662 | 645 | 1.03 | 0.0000434 | 6963 |
| Missense in Polyphen | 213 | 201.87 | 1.0551 | 2318 | ||
| Synonymous | 0.503 | 273 | 284 | 0.962 | 0.0000196 | 2212 |
| Loss of Function | 3.09 | 40 | 67.3 | 0.594 | 0.00000357 | 693 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000627 | 0.000626 |
| Ashkenazi Jewish | 0.000198 | 0.000198 |
| East Asian | 0.000437 | 0.000435 |
| Finnish | 0.000236 | 0.000185 |
| European (Non-Finnish) | 0.00102 | 0.000950 |
| Middle Eastern | 0.000437 | 0.000435 |
| South Asian | 0.000458 | 0.000457 |
| Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in cytotoxic granule exocytosis in lymphocytes. Required for both granule maturation and granule docking and priming at the immunologic synapse. Regulates assembly of recycling and late endosomal structures, leading to the formation of an endosomal exocytic compartment that fuses with perforin-containing granules at the immunologic synapse and licences them for exocytosis. Regulates Ca(2+)-dependent secretory lysosome exocytosis in mast cells. {ECO:0000269|PubMed:15548590, ECO:0000269|PubMed:17237785}.;
- Disease
- DISEASE: Familial hemophagocytic lymphohistiocytosis 3 (FHL3) [MIM:608898]: A rare disorder characterized by immune dysregulation with hypercytokinemia, defective function of natural killer cell, and massive infiltration of several organs by activated lymphocytes and macrophages. The clinical features of the disease include fever, hepatosplenomegaly, cytopenia, and less frequently neurological abnormalities ranging from irritability and hypotonia to seizures, cranial nerve deficits and ataxia. {ECO:0000269|PubMed:14622600}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer;Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.160
Intolerance Scores
- loftool
- 0.763
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.44
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.611
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.823
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Unc13d
- Phenotype
- homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- granuloma formation;germinal center formation;phagocytosis;regulation of mast cell degranulation;neutrophil degranulation;natural killer cell degranulation;positive regulation of exocytosis;defense response to virus;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of regulated secretory pathway
- Cellular component
- extracellular region;lysosome;late endosome;cytosol;membrane;Weibel-Palade body;azurophil granule lumen;intracellular membrane-bounded organelle;recycling endosome;exocytic vesicle
- Molecular function
- protein binding;Rab GTPase binding